• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy

Primary Sidebar

  • Overview
  • About Sjögren’s
  • Contact
Home - Science - Research Centers - Oklahoma Sjögren’s Syndrome Center of Research Translation (OSSCORT)

Oklahoma Sjögren’s Syndrome Center of Research Translation (OSSCORT)

Overview

The Oklahoma Sjögren’s Syndrome Center of Research Translation (OSSCORT) has been developed with the goal of implementing the resources and administrative structure to facilitate the translation of laboratory-based research in Sjögren’s syndrome into relevant diagnostic, prognostic and therapeutic innovations in the field of autoimmune disease.

The OSSCORT has the unique opportunity to bring together a strong core of well-funded laboratory-based scientists and clinical researchers at the Oklahoma Medical Research Foundation, with a multidisciplinary network of investigators committed to Sjögren’s syndrome research from the University of Oklahoma Health Sciences Center and multiple U.S. and international sites.

The OSSCORT’s first phase consists of three projects:

  • Project 1 addresses the genetics of SS by applying state-of-the-art genome wide association, fine-mapping and replication experiments, as well as genotypic delineation of sub-phenotypes.
  • Project 2 has developed innovative approaches to reveal key features of T cell immune dysregulation in Sjögren’s
  • Project 3 utilizes in vitro and a humanized mouse model of SS to test the hypothesis that B cells infiltrating the salivary glands of patients make autoantibodies that are in part responsible for the exocrine glandular dysfunction.

Three cores support the OSSCORT, which also has supported a highly productive Enrichment Program. The Cores that assist and facilitate the OSSCORT are an Administrative Core, a Clinical Core and a Data Analysis and Bioinformatics Core.

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace